TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
NKTR

Nektar Therapeutics

Healthcare · Biotechnology

60.50$ +2.2% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow NKTR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-16.79 -8.28 -12.57 -7.73 59.81 -28.17 -26.31 -33.77 -24.37 -15.21 -12.82 -12.36
1.53 1.46 1.65 1.42 0.91 1.13 1.19 1.16 1.04 0.62 0.32 -0.27
2.01 2.23 2.78 3.52 7.34 8.55 7.92 7.75 4.59 2.64 1.58 0.75
1.82 1.98 1.42 2.32 6.33 7.59 6.38 9.83 4.06 – – –
-13.76 -3.93 0.85 -3.62 -3.25 1.86 1.40 -1.89 0.04 -1.56 -0.46 -2.19
1.18 1.27 0.69 0.93 1.19 2.25 0.61 1.23 0.45 0.07 0.11 0.01
-4.44 -1.62 -8.85 -2.77 -114.92 17.73 41.68 16.59 29.32 11.02 10.40 -0.07
0.00 0.00 0.00 0.00 – – – – – – – –
19.33 3.65 22.52 5.72 70.95 2.00 1.97 2.72 – 0.00 -0.22 0.00
-0.42 11.16 -0.64 -0.49 -20.82 -21.43 -21.00 0.00 0.00 – – –
18.09 14.81 21.88 5.23 70.95 2.00 -6.75 2.97 0.12 0.00 3.07 10.70
-3.16 4.89 0.44 -5.28 15.83 -8.45 8.62 -14.22 5.05 -4.18 0.65 -1.73
-17.97 -9.54 -13.26 -8.67 58.63 -30.43 -26.92 -35.00 -24.82 -15.27 -12.92 -12.37

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?